Evaluating the Psychiatric Sequelae of Long-Term Anti-Epileptic Medication Use in Adult Epilepsy Patients in Pakistan
DOI:
https://doi.org/10.69980/ajpr.v28i1.186Keywords:
Epilepsy, Anti-epileptic drugs, Psychiatric comorbidity, Depression, Anxiety, Polytherapy, Long-term drug therapy, Pakistan, Neuropsychiatric effects, Seizure managementAbstract
Background: Long term anti epileptic drug (AED) therapy is required for epilepsy, a disorder of the nervous system, for which the sequelae might be associated with significant psychiatric problems. However, despite growing international awareness, there are few data from lower and lower-income countries such as Pakistan, where integrated neuropsychiatric screening is rarely practiced. The purpose of this study was to determine the prevalence and predictors of psychiatric morbidity in adult epilepsy patients on prolonged AED treatment.
Methods: The study was conducted cross-sectionally at Ghurki Trust Teaching Hospital, Lahore, and Farooq Hospital, Lahore, Pakistan from November 2023 to October 2024 . Forty-five adult patients (≥ 18 years) with a proven diagnosis of epilepsy and on AED therapy for 12 months or more were enrolled. Hospital Anxiety and Depression Scale (HADS) and Mini International Neuropsychiatric Interview (MINI) were used to assess psychiatric symptoms. Demographic, clinical, pharmacologic, and biochemical data (serum B12, folate, and calcium) were recorded and analyzed in SPSS version 27.0
Results: 60% of patients had depression (HADS ≥8) and 48% anxiety. Major depressive disorder was diagnosed in 26%, generalized anxiety disorder in 18%, and psychotic symptoms in 6% by MINI-based diagnoses. A significantly greater psychiatric morbidity was found in patients on polytherapy than in those on monotherapy (p < 0.05). More commonly, polytherapy users had nutritional deficiencies. There was a significant correlation between longer AED duration and higher depression scores (p = 0.031, R² = 0.42).
Conclusion: Adult epilepsy patients on long-term AEDs have a high prevalence of psychiatric morbidity, especially those on polytherapy and older agents. Improvement in neuropsychiatric outcomes in epilepsy care requires routine psychiatric screening and optimization of AED regimens.
References
1. 1. Chen B, Choi H, Hirsch LJ, Katz A, Legge A, Buchsbaum R, et al. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy. Epilepsy Behav. 2017;76:24-31.doi: 10.1016/j.yebeh.2017.08.039
2. 2. Ayaz M, Ali A, Bibi R, Iqbal MM, Iqbal A, Samreen S, et al. Retrospective evaluation of prescribing pattern and utilization of antiepileptic drugs in pediatric, neurosurgery, and psychiatry wards: A comparative study to the standard treatment guidelines. Medicine (Baltimore). 2024;103(40):e39818.doi: 10.1097/md.0000000000039818
3. 3. Mogal Z, Aziz H. Epilepsy treatment gap and stigma reduction in Pakistan: A tested public awareness model. Epilepsy & Behavior. 2020;102:106637.doi: https://doi.org/10.1016/j.yebeh.2019.106637
4. 4. Landmark CJ, Fossmark H, Larsson PG, Rytter E, Johannessen SI. Prescription patterns of antiepileptic drugs in patients with epilepsy in a nation-wide population. Epilepsy Res. 2011;95(1-2):51-9.doi: 10.1016/j.eplepsyres.2011.02.012
5. 5. Mohamed IN, Elseed MA, Hamed AA, Abdel-Rahman ME, El-Sadig SM, Omer IM, et al. Prevalence of epilepsy in 74,949 school children in Khartoum State, Sudan. Paediatr Int Child Health. 2017;37(3):188-92.doi: 10.1080/20469047.2016.1278110
6. 6. Jameel I, Khan M, Jami A, Khan AN, Hassan ZU, Razzaq M. The impact of early life epilepsy on long term neurological development: a comprehensive study of pediatric patients: Early Life Epilepsy Outcomes. DEVELOPMENTAL MEDICO-LIFE-SCIENCES. 2024;1(9):41-9.doi: 10.69750/dmls.01.09.080
7. 7. Mazhar F, Shamim S, Malhi S. Drug utilization evaluation of antiepileptics in three selected multidisciplinary teaching hospitals of Pakistan. International Journal of Pharmacy and Pharmaceutical Sciences. 2014;6:59-66.doi,
8. 8. Shorvon SD. Drug treatment of epilepsy in the century of the ILAE: The second 50 years, 1959–2009. Epilepsia. 2009;50(s3):93-130.doi: https://doi.org/10.1111/j.1528-1167.2009.02042.x
9. 9. Asghar MA, Rehman AA, Raza ML, Shafiq Y, Asghar MA. Analysis of treatment adherence and cost among patients with epilepsy: a four‐year retrospective cohort study in Pakistan. BMC Health Services Research. 2021;21(1):72.doi: 10.1186/s12913-021-06085-0
10. 10. Bashatah AS, Syed W, Al-Rawi MBA, Al Arifi MN. Assessment of Headache Characteristics, Impact, and Managing Techniques among Pharmacy and Nursing Undergraduates-An Observational Study. Medicina (Kaunas). 2023;59(1).doi: 10.3390/medicina59010130
11. 11. Shahid R, Akram M, Ayub M, Nadeem M, Fatima E, Haroon AM, et al. Prevalence and Correlates of Psychiatric Symptoms Among Medical Students in Punjab: A Comprehensive Cross-Sectional Study: Mental Health Insights: Psychiatric Symptoms Among Punjab Medical Students. DEVELOPMENTAL MEDICO-LIFE-SCIENCES. 2024;1(3):13-9.doi: 10.69750/dmls.01.03.029
12. 12. Alqahtani F, Al Awadh SA, Rasool MF. Exploring the Pharmacokinetics of Drugs in Disabled Saudi Patients: A Systematic Review. Pharmaceuticals [Internet]. 2025; 18(4).doi: 10.3390/ph18040582
13. 13. Bosak M, Słowik A, Iwańska A, Lipińska M, Turaj W. Co-medication and potential drug interactions among patients with epilepsy. Seizure. 2019;66:47-52.doi: 10.1016/j.seizure.2019.01.014
14. 14. Karaźniewicz-Łada M, Główka AK, Mikulska AA, Główka FK. Pharmacokinetic Drug-Drug Interactions among Antiepileptic Drugs, Including CBD, Drugs Used to Treat COVID-19 and Nutrients. Int J Mol Sci. 2021;22(17).doi: 10.3390/ijms22179582
15. 15. Arulsamy A, Shaikh MF. Epilepsy-associated comorbidities among adults: A plausible therapeutic role of gut microbiota. Neurobiol Dis. 2022;165:105648.doi: 10.1016/j.nbd.2022.105648
16. 16. Gao H, Sander JW, Xiao Y, Zhang Y, Zhou D. A comparison between the 1981 and 2017 International League Against Epilepsy classification of seizure types based on an outpatient setting. Epileptic Disord. 2018;20(4):257-64.doi: 10.1684/epd.2018.0982
17. 17. Thijs RD, Surges R, O'Brien TJ, Sander JW. Epilepsy in adults. Lancet. 2019;393(10172):689-701.doi: 10.1016/s0140-6736(18)32596-0
18. 18. Khatri IA, Iannaccone ST, Ilyas MS, Abdullah M, Saleem S. Epidemiology of epilepsy in Pakistan: review of literature. J Pak Med Assoc. 2003;53(12):594-7.doi,
19. 19. Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217-24.doi: 10.1016/s0140-6736(20)30611-5
20. 20. Parikh SK, Silberstein SD. Current Status of Antiepileptic Drugs as Preventive Migraine Therapy. Curr Treat Options Neurol. 2019;21(4):16.doi: 10.1007/s11940-019-0558-1
21. 21. Kurvits K, Laius O, Uusküla M, Haldre S, Rakitin A. Valproic acid prescription trends among females of childbearing age in Estonia: A 14-year nationwide prescription database study. Seizure. 2020;76:28-31.doi: 10.1016/j.seizure.2020.01.004
22. 22. Willems LM, Hamer HM, Knake S, Rosenow F, Reese JP, Strzelczyk A. General Trends in Prices and Prescription Patterns of Anticonvulsants in Germany between 2000 and 2017: Analysis of National and Cohort-Based Data. Appl Health Econ Health Policy. 2019;17(5):707-22.doi: 10.1007/s40258-019-00487-2
23. 23. Willems LM, Richter S, Watermann N, Bauer S, Klein KM, Reese JP, et al. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany from 2003 to 2013 - A ten-year overview. Epilepsy Behav. 2018;83:28-35.doi: 10.1016/j.yebeh.2018.03.025
Downloads
Published
Issue
Section
License
Copyright (c) 2025 American Journal of Psychiatric Rehabilitation
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License permitting all use, distribution, and reproduction in any medium, provided the work is properly cited.
